Skip to main content
. 2012 May;27(4):243–251. doi: 10.1089/cbr.2011.1088

Table 1A.

Biodistribution of 125I-PSA30 Administered Intravenously in Nontumor-Bearing Mice (n=14)

 
125I-PSA30–%IA/g
Tissue 6 hours (n=3) 24 hours (n=3) 96 hours (n=3) 168 hours (n=2) 312 hours (n=3)
Blood 13.12±12.99 2.52±2.26 3.76±0.56 2.27±0.40 1.32±0.61
Spleen 3.20±2.66 0.71±0.78 1.03±0.60 0.51±0.00 0.31±0.17
Lungs 4.47±3.39 0.97±1.05 1.20±0.13 0.84±0.13 0.43±0.19
Kidneys 4.04±3.18 0.69±0.63 1.04±0.11 0.49±0.23 0.28±0.16
Liver 1.64±1.62 0.75±0.79 0.85±0.08 0.48±0.14 0.24±0.12
Bone marrow 6.21±5.44 1.36±1.23 2.26±1.78 1.28±0.00 0.82±0.55
Prostate 2.34±2.08 0.55±0.58 0.72±0.16 0.66±0.13 0.41±0.11
Muscle 0.46±0.25 0.18±0.17 0.26±0.04 0.15±0.01 0.09±0.05
Brain 0.29±0.22 0.07±0.07 0.08±0.01 0.05±0.01 0.03±0.01
Thyroida 6.0±5.8 14±22 26±8.0 19±3.0 25±5.0

Mean±standard deviation.

a

Thyroid data presented as % IA per whole organ, not per gram.

PSA, prostate-specific antigen; % IA/g, percentage of injected activity per gram of tissue.